**MedTech Acquisition Announces Leadership Transition and Salary Investment Program**

MedTech Acquisition (OTCMKTS:MTACU) recently disclosed its current report with the Securities and Exchange Commission (SEC) dated January 4, 2025. The report outlined significant updates, primarily involving the appointment of new key executives and the initiation of a salary investment program. TriSalus Life Sciences, Inc., a subsidiary of MedTech Acquisition, confirmed, effective January 6, 2025, a […]

Leave a Reply

Your email address will not be published.

Previous post CJM Wealth Advisers Ltd. Raises Stock Holdings in The Home Depot, Inc. (NYSE:HD)
Next post Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Investors